Ionis Pharmaceuticals IncNASDAQ:IONS
- LAST PRICE40.7650
- TODAY'S CHANGE (%)-0.2250 (-0.5489%)
- Bid / Lots40.7400/ 4
- Ask / Lots40.7900/ 1
- Open / Previous Close41.1600 / 40.9900
- Day Range
- 52 Week Range
- Volume813,429
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | IONS |
|---|---|---|
| 09:32 ET | 6051 | 41.16 |
| 09:34 ET | 500 | 41.135 |
| 09:36 ET | 100 | 40.96 |
| 09:41 ET | 250 | 41.088 |
| 09:45 ET | 1690 | 41.155 |
| 09:48 ET | 1775 | 41.205 |
| 09:50 ET | 1561 | 41.215 |
| 09:52 ET | 1513 | 41.18 |
| 09:54 ET | 1800 | 41.09 |
| 09:56 ET | 1834 | 41.1 |
| 09:57 ET | 7181 | 41.22 |
| 09:59 ET | 100 | 41.21 |
| 10:01 ET | 5151 | 41.21 |
| 10:03 ET | 3729 | 41.09 |
| 10:06 ET | 1277 | 41.04 |
| 10:08 ET | 800 | 40.99 |
| 10:10 ET | 2205 | 40.95 |
| 10:12 ET | 897 | 40.98 |
| 10:14 ET | 2104 | 41.02 |
| 10:15 ET | 4594 | 41 |
| 10:17 ET | 1390 | 41.06 |
| 10:19 ET | 2425 | 41.1 |
| 10:21 ET | 1286 | 41.07 |
| 10:24 ET | 500 | 41.035 |
| 10:26 ET | 2700 | 41.015 |
| 10:28 ET | 1530 | 41.06 |
| 10:30 ET | 2251 | 40.95 |
| 10:32 ET | 1100 | 41.01 |
| 10:33 ET | 2200 | 41.035 |
| 10:35 ET | 125 | 41.0494 |
| 10:37 ET | 1710 | 41.11 |
| 10:39 ET | 1712 | 41.09 |
| 10:42 ET | 1870 | 41.09 |
| 10:44 ET | 1303 | 41.03 |
| 10:46 ET | 1000 | 41.02 |
| 10:48 ET | 6202 | 41.09 |
| 10:50 ET | 400 | 41.05 |
| 10:51 ET | 1017 | 41.075 |
| 10:53 ET | 2030 | 41.02 |
| 10:55 ET | 1623 | 40.97 |
| 10:57 ET | 714 | 40.97 |
| 11:00 ET | 2206 | 40.96 |
| 11:02 ET | 700 | 40.96 |
| 11:04 ET | 2000 | 41.0023 |
| 11:06 ET | 1159 | 40.97 |
| 11:08 ET | 500 | 40.9857 |
| 11:09 ET | 900 | 41.05 |
| 11:11 ET | 2077 | 40.975 |
| 11:13 ET | 742 | 41 |
| 11:15 ET | 925 | 40.99 |
| 11:18 ET | 1000 | 41.01 |
| 11:22 ET | 4816 | 40.99 |
| 11:24 ET | 15700 | 40.94 |
| 11:26 ET | 100 | 40.94 |
| 11:27 ET | 1142 | 40.92 |
| 11:29 ET | 1257 | 40.95 |
| 11:31 ET | 9590 | 40.97 |
| 11:33 ET | 400 | 41.005 |
| 11:36 ET | 2721 | 40.96 |
| 11:44 ET | 100 | 40.98 |
| 11:45 ET | 100 | 40.96 |
| 11:47 ET | 543 | 41 |
| 11:49 ET | 100 | 40.985 |
| 11:51 ET | 100 | 40.98 |
| 11:54 ET | 1252 | 40.985 |
| 11:56 ET | 300 | 40.995 |
| 11:58 ET | 3210 | 40.97 |
| 12:00 ET | 10354 | 40.92 |
| 12:02 ET | 2000 | 40.9801 |
| 12:03 ET | 3400 | 40.99 |
| 12:05 ET | 924 | 40.95 |
| 12:07 ET | 1100 | 40.935 |
| 12:09 ET | 1700 | 40.98 |
| 12:12 ET | 100 | 40.975 |
| 12:14 ET | 521 | 40.945 |
| 12:16 ET | 1852 | 40.91 |
| 12:18 ET | 1798 | 40.875 |
| 12:20 ET | 1600 | 40.92 |
| 12:21 ET | 100 | 40.93 |
| 12:23 ET | 2692 | 40.82 |
| 12:25 ET | 300 | 40.83 |
| 12:27 ET | 241 | 40.815 |
| 12:30 ET | 6600 | 40.865 |
| 12:32 ET | 2584 | 40.83 |
| 12:34 ET | 6163 | 40.86 |
| 12:36 ET | 800 | 40.86 |
| 12:38 ET | 1823 | 40.885 |
| 12:39 ET | 13439 | 40.91 |
| 12:41 ET | 11421 | 40.925 |
| 12:43 ET | 1144 | 40.945 |
| 12:45 ET | 300 | 40.92 |
| 12:48 ET | 15096 | 40.97 |
| 12:50 ET | 96354 | 40.945 |
| 12:52 ET | 2600 | 41.11 |
| 12:54 ET | 1943 | 41.21 |
| 12:56 ET | 3701 | 41.24 |
| 12:57 ET | 3246 | 41.1 |
| 12:59 ET | 200 | 41.14 |
| 01:01 ET | 573 | 41.17 |
| 01:03 ET | 68942 | 41.175 |
| 01:06 ET | 46000 | 41.175 |
| 01:08 ET | 25118 | 41.33 |
| 01:10 ET | 6730 | 41.3 |
| 01:12 ET | 49617 | 41.19 |
| 01:14 ET | 101400 | 41 |
| 01:15 ET | 500 | 41 |
| 01:17 ET | 1601 | 40.99 |
| 01:19 ET | 800 | 40.93 |
| 01:21 ET | 1729 | 40.865 |
| 01:24 ET | 1200 | 40.865 |
| 01:26 ET | 9241 | 40.7666 |
| 01:28 ET | 1050 | 40.76 |
| 01:30 ET | 1063 | 40.785 |
| 01:32 ET | 2100 | 40.86 |
| 01:33 ET | 995 | 40.82 |
| 01:35 ET | 1737 | 40.745 |
| 01:37 ET | 1500 | 40.76 |
| 01:39 ET | 6641 | 40.71 |
| 01:42 ET | 1120 | 40.735 |
| 01:44 ET | 1200 | 40.71 |
| 01:46 ET | 1050 | 40.71 |
| 01:48 ET | 2100 | 40.725 |
| 01:50 ET | 1300 | 40.73 |
| 01:51 ET | 3290 | 40.765 |
Today
Sep 12, 2024
DJ The Brawl Taking Shape Over Pfizer's Multibillion-Dollar Heart Monopoly -- Heard on the Street -- Update, from 1:01PM ET on Thursday Sep 12, 2024 by Dow Jones
1:01PM ET on Thursday Sep 12, 2024 by Dow JonesDJ The Brawl Taking Shape Over Pfizer's Multibillion-Dollar Heart Monopoly -- Heard on the Street -- WSJ, from 7:00AM ET on Thursday Sep 12, 2024 by Dow Jones
7:00AM ET on Thursday Sep 12, 2024 by Dow Jones
Sep 10, 2024
DJ Ionis Pharmaceuticals Down Over 10%, on Pace for Largest Percent Decrease Since May 2022 -- Data Talk, from 11:52AM ET on Tuesday Sep 10, 2024 by Dow Jones
11:52AM ET on Tuesday Sep 10, 2024 by Dow JonesDJ S&P 500 Futures Steady In Premarket Trading; Oracle, Sonoco Products Lead, from 7:30AM ET on Tuesday Sep 10, 2024 by Dow Jones
7:30AM ET on Tuesday Sep 10, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Ionis Pharmaceuticals Inc | 6.5B | -16.1x | --- |
Halozyme Therapeutics Inc | 7.1B | 22.0x | --- |
Tempus AI Inc | 7.6B | -6.1x | --- |
Intra-Cellular Therapies Inc | 7.9B | -85.6x | --- |
Ultragenyx Pharmaceutical Inc | 5.2B | -7.6x | --- |
ACADIA Pharmaceuticals Inc | 2.5B | 84.7x | --- |
Company Information
Ionis Pharmaceuticals, Inc. is engaged in ribonucleic acid (RNA)-targeted therapeutics. The Company has five marketed medicines and a pipeline in neurology, cardiology, and other areas of high patient need. It has nine medicines in Phase III development and multiple additional medicines in early and mid-stage development. The Company’s products include SPINRAZA, QALSODY, WAINUA, TEGSEDI and WAYLIVRA. SPINRAZA is used for the treatment of patients with spinal muscular atrophy (SMA), a progressive, debilitating and often fatal genetic disease. QALSODY is an antisense medicine that is used for the treatment of adult patients with superoxide dismutase 1 amyotrophic lateral sclerosis (SOD1-ALS), a rare, neurodegenerative disorder that causes progressive loss of motor neurons leading to death. WAINUA is a self-administered subcutaneous LIgand-Conjugated Antisense (LICA) medicine used for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated amyloidosis (ATTRv-PN).
Contact Information
- Headquarters
- 2855 Gazelle CourtCARLSBAD, CA, United States 92010
- Phone
- 760-931-9200
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Joseph Loscalzo
- Chief Executive Officer, Director
- Brett Monia
- Chief Financial Officer, Executive Vice President - Finance
- Elizabeth Hougen
- Executive Vice President, Chief Scientific Officer
- C. Frank Bennett
- Executive Vice President, Chief Business Officer
- Joseph Baroldi
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $6.5B |
|---|---|
Revenue (TTM) | $813.5M |
Shares Outstanding | 157.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.39 |
EPS | $-2.53 |
Book Value | $2.68 |
P/E Ratio | -16.1x |
Price/Sales (TTM) | 7.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -44.61% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
